Anika Therapeutics, Inc. Selling, General and Administrative Expense
Anika Therapeutics, Inc. (ANIK) reported Selling, General and Administrative Expense of $10.95 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:SellingGeneralAndAdministrativeExpense · last filed 2026-07-29
- Anika Therapeutics, Inc. selling, general and administrative expense for the quarter ending 2026-06-30 was $10.95M, a 10.47% decline year-over-year.
- Anika Therapeutics, Inc. selling, general and administrative expense for the quarter ending 2026-03-31 was $17.77M, a 37.70% increase year-over-year.
- Anika Therapeutics, Inc. selling, general and administrative expense for the quarter ending 2025-12-31 was $12.08M, a 6.68% increase year-over-year.
- Anika Therapeutics, Inc. selling, general and administrative expense for the quarter ending 2025-09-30 was $11.87M, a 12.35% decline year-over-year.
- Anika Therapeutics, Inc. selling, general and administrative expense for fiscal 2025 was $49.09M, a 11.64% decline from fiscal 2024.
- Anika Therapeutics, Inc. selling, general and administrative expense for fiscal 2024 was $55.55M, a 7.29% decline from fiscal 2023.
- Anika Therapeutics, Inc. selling, general and administrative expense for fiscal 2023 was $59.92M, a 16.97% increase from fiscal 2022.
- Anika Therapeutics, Inc. selling, general and administrative expense for fiscal 2022 was $51.23M, a 30.86% decline from fiscal 2021.
| Period end | Selling, General and Administrative Expense 3 month | Selling, General and Administrative Expense 3 month as first filed | Selling, General and Administrative Expense 6 month | Selling, General and Administrative Expense 6 month as first filed | Selling, General and Administrative Expense 9 month | Selling, General and Administrative Expense 9 month as first filed | Selling, General and Administrative Expense 12 month | Selling, General and Administrative Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $10.95M 10-Q · filed 2026-07-29 | $28.72M 10-Q · filed 2026-07-29 | $40.80M derived: sum of 3 quarters · filed 2026-07-29 | $52.67M derived: sum of 4 quarters · filed 2026-07-29 | ||||
| 2026-03-31 | $17.77M 10-Q · filed 2026-04-30 | $29.85M derived: sum of 2 quarters · filed 2026-04-30 | $41.72M derived: sum of 3 quarters · filed 2026-04-30 | $53.95M derived: sum of 4 quarters · filed 2026-07-29 | ||||
| 2025-12-31 | $12.08M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | $23.95M derived: sum of 2 quarters · filed 2026-03-03 | $36.18M derived: sum of 3 quarters · filed 2026-07-29 | $49.09M 10-K · filed 2026-03-03 | ||||
| 2025-09-30 | $11.87M 10-Q · filed 2025-11-05 | $24.10M derived: sum of 2 quarters · filed 2026-07-29 | $37.01M 10-Q · filed 2025-11-05 | $48.33M derived: sum of 4 quarters · filed 2026-07-29 | ||||
| 2025-06-30 | $12.23M 10-Q · filed 2026-07-29 | $25.14M 10-Q · filed 2026-07-29 | $36.46M derived: sum of 3 quarters · filed 2026-07-29 | $50.00M derived: sum of 4 quarters · filed 2026-07-29 | ||||
| 2025-03-31 | $12.91M 10-Q · filed 2026-04-30 | $24.23M derived: sum of 2 quarters · filed 2026-04-30 | $37.77M derived: sum of 3 quarters · filed 2026-04-30 | $53.39M derived: sum of 4 quarters · filed 2026-04-30 | ||||
| 2024-12-31 | $11.32M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | $24.87M derived: sum of 2 quarters · filed 2026-03-03 | $40.48M derived: sum of 3 quarters · filed 2026-03-03 | $55.55M 10-K · filed 2026-03-03 | ||||
| 2024-09-30 | $13.54M 10-Q · filed 2025-11-05 | $19.11M 10-Q · filed 2024-11-04 | $29.16M derived: sum of 2 quarters · filed 2025-11-05 | $44.23M 10-Q · filed 2025-11-05 | $60.45M 10-Q · filed 2024-11-04 | $28.64M derived: sum of 4 quarters · filed 2026-03-03 | ||
| 2024-06-30 | $15.62M 10-Q · filed 2025-07-30 | $19.81M 10-Q · filed 2024-08-08 | $30.69M 10-Q · filed 2025-07-30 | $41.33M 10-Q · filed 2024-08-08 | $15.10M derived: sum of 3 quarters · filed 2026-03-03 | $39.93M derived: sum of 4 quarters · filed 2026-03-03 | ||
| 2024-03-31 | $15.07M 10-Q · filed 2025-05-09 | $21.53M 10-Q · filed 2024-05-08 | -$516.00K derived: sum of 2 quarters · filed 2026-03-03 | $24.31M derived: sum of 3 quarters · filed 2026-03-03 | $48.00M derived: sum of 4 quarters · filed 2026-03-03 | |||
| 2023-12-31 | -$15.59M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | $9.24M derived: sum of 2 quarters · filed 2026-03-03 | $32.93M derived: sum of 3 quarters · filed 2026-03-03 | $59.92M 10-K · filed 2026-03-03 | $95.85M 10-K · filed 2024-03-15 | |||
| 2023-09-30 | $24.83M 10-Q · filed 2024-11-04 | $48.52M derived: sum of 2 quarters · filed 2024-11-04 | $75.51M 10-Q · filed 2024-11-04 | $65.00M derived: sum of 4 quarters · filed 2025-03-17 | ||||
| 2023-06-30 | $23.69M 10-Q · filed 2024-08-08 | $50.69M 10-Q · filed 2024-08-08 | $40.17M derived: sum of 3 quarters · filed 2025-03-17 | $61.45M derived: sum of 4 quarters · filed 2025-03-17 | ||||
| 2023-03-31 | $27.00M 10-Q · filed 2024-05-08 | $16.48M derived: sum of 2 quarters · filed 2025-03-17 | $37.76M derived: sum of 3 quarters · filed 2025-03-17 | $59.02M derived: sum of 4 quarters · filed 2025-03-17 | ||||
| 2022-12-31 | -$10.52M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-17 | $10.76M derived: sum of 2 quarters · filed 2025-03-17 | $32.03M derived: sum of 3 quarters · filed 2025-03-17 | $51.23M 10-K · filed 2025-03-17 | $84.79M 10-K · filed 2023-03-16 | |||
| 2022-09-30 | $21.28M 10-Q · filed 2023-11-03 | $42.54M derived: sum of 2 quarters · filed 2023-11-03 | $61.74M 10-Q · filed 2023-11-03 | $82.18M derived: sum of 4 quarters · filed 2024-03-15 | ||||
| 2022-06-30 | $21.27M 10-Q · filed 2023-08-08 | $40.47M 10-Q · filed 2023-08-08 | $60.90M derived: sum of 3 quarters · filed 2024-03-15 | $78.40M derived: sum of 4 quarters · filed 2024-03-15 | ||||
| 2022-03-31 | $19.20M 10-Q · filed 2023-05-09 | $39.63M derived: sum of 2 quarters · filed 2024-03-15 | $57.13M derived: sum of 3 quarters · filed 2024-03-15 | $75.12M derived: sum of 4 quarters · filed 2024-03-15 | ||||
| 2021-12-31 | $20.43M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-15 | $37.93M derived: sum of 2 quarters · filed 2024-03-15 | $55.92M derived: sum of 3 quarters · filed 2024-03-15 | $74.10M 10-K · filed 2024-03-15 | ||||
| 2021-09-30 | $17.50M 10-Q · filed 2022-11-09 | $35.49M derived: sum of 2 quarters · filed 2022-11-09 | $53.66M 10-Q · filed 2022-11-09 | $68.84M derived: sum of 4 quarters · filed 2023-03-16 | ||||
| 2021-06-30 | $17.99M 10-Q · filed 2022-08-04 | $36.16M 10-Q · filed 2022-08-04 | $51.34M derived: sum of 3 quarters · filed 2023-03-16 | $67.25M derived: sum of 4 quarters · filed 2023-03-16 | ||||
| 2021-03-31 | $18.18M 10-Q · filed 2022-05-06 | $33.35M derived: sum of 2 quarters · filed 2023-03-16 | $49.26M derived: sum of 3 quarters · filed 2023-03-16 | $63.81M derived: sum of 4 quarters · filed 2023-03-16 | ||||
| 2020-12-31 | $15.18M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | $31.08M derived: sum of 2 quarters · filed 2023-03-16 | $45.63M derived: sum of 3 quarters · filed 2023-03-16 | $60.06M 10-K · filed 2023-03-16 | ||||
| 2020-09-30 | $15.90M 10-Q · filed 2021-11-05 | $30.45M derived: sum of 2 quarters · filed 2021-11-05 | $44.88M 10-Q · filed 2021-11-05 | $57.12M derived: sum of 4 quarters · filed 2022-03-11 | ||||
| 2020-06-30 | $14.55M 10-Q · filed 2021-08-06 | $28.98M 10-Q · filed 2021-08-06 | $41.22M derived: sum of 3 quarters · filed 2022-03-11 | $48.76M derived: sum of 4 quarters · filed 2022-03-11 | ||||
| 2020-03-31 | $14.43M 10-Q · filed 2021-05-07 | $26.67M derived: sum of 2 quarters · filed 2022-03-11 | $34.21M derived: sum of 3 quarters · filed 2022-03-11 | $41.71M derived: sum of 4 quarters · filed 2022-03-11 | ||||
| 2019-12-31 | $12.24M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-11 | $19.78M derived: sum of 2 quarters · filed 2022-03-11 | $27.28M derived: sum of 3 quarters · filed 2022-03-11 | $34.95M 10-K · filed 2022-03-11 | ||||
| 2019-09-30 | $7.54M 10-Q · filed 2020-11-05 | $15.04M derived: sum of 2 quarters · filed 2020-11-05 | $22.71M 10-Q · filed 2020-11-05 | $28.84M derived: sum of 4 quarters · filed 2021-04-26 | ||||
| 2019-06-30 | $7.50M 10-Q · filed 2020-08-07 | $15.17M 10-Q · filed 2020-08-07 | $21.30M derived: sum of 3 quarters · filed 2021-04-26 | $27.00M derived: sum of 4 quarters · filed 2021-04-26 | ||||
| 2019-03-31 | $7.67M 10-Q · filed 2020-05-22 | $13.80M derived: sum of 2 quarters · filed 2021-04-26 | $19.50M derived: sum of 3 quarters · filed 2021-04-26 | $25.92M derived: sum of 4 quarters · filed 2021-04-26 | ||||
| 2018-12-31 | $6.13M derived: 10-K/A 12 month − 10-Q 9 month · filed 2021-04-26 | $11.83M derived: sum of 2 quarters · filed 2021-04-26 | $18.25M derived: sum of 3 quarters · filed 2021-04-26 | $34.34M 10-K/A · filed 2021-04-26 | ||||
| 2018-09-30 | $5.70M 10-Q · filed 2019-10-28 | $12.12M derived: sum of 2 quarters · filed 2019-10-28 | $28.21M 10-Q · filed 2019-10-28 | $34.88M derived: sum of 4 quarters · filed 2020-03-06 | ||||
| 2018-06-30 | $6.42M 10-Q · filed 2019-07-26 | $22.51M 10-Q · filed 2019-07-26 | $29.18M derived: sum of 3 quarters · filed 2020-03-06 | $34.01M derived: sum of 4 quarters · filed 2020-03-06 | ||||
| 2018-03-31 | $16.09M 10-Q · filed 2019-05-06 | $22.77M derived: sum of 2 quarters · filed 2020-03-06 | $27.59M derived: sum of 3 quarters · filed 2020-03-06 | $32.56M derived: sum of 4 quarters · filed 2020-03-06 | ||||
| 2017-12-31 | $6.68M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-06 | $11.50M derived: sum of 2 quarters · filed 2020-03-06 | $16.47M derived: sum of 3 quarters · filed 2020-03-06 | $21.54M 10-K · filed 2020-03-06 | ||||
| 2017-09-30 | $4.82M 10-Q · filed 2018-10-26 | $9.79M derived: sum of 2 quarters · filed 2018-10-26 | $14.86M 10-Q · filed 2018-10-26 | $20.35M derived: sum of 4 quarters · filed 2019-02-27 | ||||
| 2017-06-30 | $4.97M 10-Q · filed 2018-07-31 | $10.04M 10-Q · filed 2018-07-31 | $15.53M derived: sum of 3 quarters · filed 2019-02-27 | $19.81M derived: sum of 4 quarters · filed 2019-02-27 | ||||
| 2017-03-31 | $5.07M 10-Q · filed 2018-05-10 | $10.55M derived: sum of 2 quarters · filed 2019-02-27 | $14.84M derived: sum of 3 quarters · filed 2019-02-27 | $19.09M derived: sum of 4 quarters · filed 2019-02-27 | ||||
| 2016-12-31 | $5.49M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27 | $9.77M derived: sum of 2 quarters · filed 2019-02-27 | $14.02M derived: sum of 3 quarters · filed 2019-02-27 | $18.01M 10-K · filed 2019-02-27 | ||||
| 2016-09-30 | $4.28M 10-Q · filed 2017-10-27 | $8.54M derived: sum of 2 quarters · filed 2017-10-27 | $12.53M 10-Q · filed 2017-10-27 | $17.05M derived: sum of 4 quarters · filed 2018-02-27 | ||||
| 2016-06-30 | $4.25M 10-Q · filed 2017-07-28 | $8.24M 10-Q · filed 2017-07-28 | $12.77M derived: sum of 3 quarters · filed 2018-02-27 | $16.08M derived: sum of 4 quarters · filed 2018-02-27 | ||||
| 2016-03-31 | $3.99M 10-Q · filed 2017-05-04 | $8.51M derived: sum of 2 quarters · filed 2018-02-27 | $11.82M derived: sum of 3 quarters · filed 2018-02-27 | $15.21M derived: sum of 4 quarters · filed 2018-02-27 | ||||
| 2015-12-31 | $4.52M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $7.83M derived: sum of 2 quarters · filed 2018-02-27 | $11.22M derived: sum of 3 quarters · filed 2018-02-27 | $14.82M 10-K · filed 2018-02-27 | ||||
| 2015-09-30 | $3.31M 10-Q · filed 2016-11-01 | $3.31M 10-Q · filed 2015-11-03 | $6.70M derived: sum of 2 quarters · filed 2016-11-01 | $10.30M 10-Q · filed 2016-11-01 | $10.30M 10-Q · filed 2015-11-03 | $13.97M derived: sum of 4 quarters · filed 2017-02-24 | ||
| 2015-06-30 | $3.39M 10-Q · filed 2016-08-01 | $3.39M 10-Q · filed 2015-08-04 | $6.99M 10-Q · filed 2016-08-01 | $6.99M 10-Q · filed 2015-08-04 | $10.67M derived: sum of 3 quarters · filed 2017-02-24 | $14.71M derived: sum of 4 quarters · filed 2017-02-24 | ||
| 2015-03-31 | $3.60M 10-Q · filed 2016-05-03 | $3.60M 10-Q · filed 2015-05-04 | $7.28M derived: sum of 2 quarters · filed 2017-02-24 | $11.32M derived: sum of 3 quarters · filed 2017-02-24 | $15.19M derived: sum of 4 quarters · filed 2017-02-24 | |||
| 2014-12-31 | $3.67M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-24 | $7.72M derived: sum of 2 quarters · filed 2017-02-24 | $11.58M derived: sum of 3 quarters · filed 2017-02-24 | $15.07M 10-K · filed 2017-02-24 | $15.07M 10-K · filed 2015-03-13 | |||
| 2014-09-30 | $4.04M 10-Q · filed 2015-11-03 | $7.91M derived: sum of 2 quarters · filed 2015-11-03 | $11.40M 10-Q · filed 2015-11-03 | $13.80M derived: sum of 4 quarters · filed 2016-03-10 | ||||
| 2014-06-30 | $3.87M 10-Q · filed 2015-08-04 | $7.36M 10-Q · filed 2015-08-04 | $9.76M derived: sum of 3 quarters · filed 2016-03-10 | $12.95M derived: sum of 4 quarters · filed 2016-03-10 | ||||
| 2014-03-31 | $3.49M 10-Q · filed 2015-05-04 | $5.89M derived: sum of 2 quarters · filed 2016-03-10 | $9.08M derived: sum of 3 quarters · filed 2016-03-10 | $12.48M derived: sum of 4 quarters · filed 2016-03-10 | ||||
| 2013-12-31 | $2.40M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-10 | $5.59M derived: sum of 2 quarters · filed 2016-03-10 | $8.99M derived: sum of 3 quarters · filed 2016-03-10 | $12.94M 10-K · filed 2016-03-10 | $12.94M 10-K · filed 2014-03-13 | |||
| 2013-09-30 | $3.19M 10-Q · filed 2014-11-06 | $6.59M derived: sum of 2 quarters · filed 2014-11-06 | $10.54M 10-Q · filed 2014-11-06 | $14.20M derived: sum of 4 quarters · filed 2015-03-13 | ||||
| 2013-06-30 | $3.40M 10-Q · filed 2014-08-04 | $7.35M 10-Q · filed 2014-08-04 | $11.02M derived: sum of 3 quarters · filed 2015-03-13 | $14.62M derived: sum of 4 quarters · filed 2015-03-13 | ||||
| 2013-03-31 | $3.95M 10-Q · filed 2014-05-05 | $7.61M derived: sum of 2 quarters · filed 2015-03-13 | $11.22M derived: sum of 3 quarters · filed 2015-03-13 | $15.32M derived: sum of 4 quarters · filed 2015-03-13 | ||||
| 2012-12-31 | $3.67M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-13 | $7.27M derived: sum of 2 quarters · filed 2015-03-13 | $11.38M derived: sum of 3 quarters · filed 2015-03-13 | $14.73M 10-K · filed 2015-03-13 | ||||
| 2012-09-30 | $3.60M 10-Q · filed 2013-11-05 | $7.71M derived: sum of 2 quarters · filed 2013-11-05 | $11.06M 10-Q · filed 2013-11-05 | $15.93M derived: sum of 4 quarters · filed 2014-03-13 | ||||
| 2012-06-30 | $4.11M 10-Q · filed 2013-08-06 | $7.46M 10-Q · filed 2013-08-06 | $12.33M derived: sum of 3 quarters · filed 2014-03-13 | $17.04M derived: sum of 4 quarters · filed 2014-03-13 | ||||
| 2012-03-31 | $3.35M 10-Q · filed 2013-05-06 | $8.22M derived: sum of 2 quarters · filed 2014-03-13 | $12.93M derived: sum of 3 quarters · filed 2014-03-13 | $17.17M derived: sum of 4 quarters · filed 2014-03-13 | ||||
| 2011-12-31 | $4.87M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-13 | $9.58M derived: sum of 2 quarters · filed 2014-03-13 | $13.81M derived: sum of 3 quarters · filed 2014-03-13 | $17.86M 10-K · filed 2014-03-13 | ||||
| 2011-09-30 | $4.71M 10-Q · filed 2012-11-08 | $8.95M derived: sum of 2 quarters · filed 2012-11-08 | $12.99M 10-Q · filed 2012-11-08 | $17.14M derived: sum of 4 quarters · filed 2013-03-14 | ||||
| 2011-06-30 | $4.23M 10-Q · filed 2012-08-07 | $8.28M 10-Q · filed 2012-08-07 | $12.43M derived: sum of 3 quarters · filed 2013-03-14 | $16.34M derived: sum of 4 quarters · filed 2013-03-14 | ||||
| 2011-03-31 | $4.04M 10-Q · filed 2012-05-07 | $8.20M derived: sum of 2 quarters · filed 2013-03-14 | $12.11M derived: sum of 3 quarters · filed 2013-03-14 | $17.07M derived: sum of 4 quarters · filed 2013-03-14 | ||||
| 2010-12-31 | $4.15M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-14 | $8.06M derived: sum of 2 quarters · filed 2013-03-14 | $13.03M derived: sum of 3 quarters · filed 2013-03-14 | $17.32M 10-K · filed 2013-03-14 | ||||
| 2010-09-30 | $3.91M 10-Q · filed 2011-11-04 | $8.88M derived: sum of 2 quarters · filed 2011-11-04 | $13.16M 10-Q · filed 2011-11-04 | |||||
| 2010-06-30 | $4.97M 10-Q/A · filed 2011-08-10 | $9.26M 10-Q/A · filed 2011-08-10 | ||||||
| 2009-12-31 | $10.55M 10-K · filed 2012-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |